Alberto Moscona-Nissan

Research fellow at Mass General Hospital @harvardmed | MD @UPMexico | IMG, aspiring physician scientist and endocrinologist |

[Alberto Moscona-Nissan @Alberto_Moscona]

Very excited to share that I will be joining @MassGenBrigham at @harvardmed as a Postdoctoral Research Fellow after passing Step 1 and graduating from Med School at @UPMexico. Incredibly grateful to my mentors, family, and friends for their constant support.

[Alberto Moscona-Nissan @Alberto_Moscona]

@Manuel_MorenoM_ @alexandersoneri @AlohaMeaveMD @ACCinTouch @Cardiology Felicidades!!

[Alberto Moscona-Nissan @Alberto_Moscona]

@alberto_guijosa @BrighamMedRes @harvardmed @UPMexico @DanaFarber Muchas felicidades!! Muy merecido!

[Alberto Moscona-Nissan @Alberto_Moscona]

Very grateful to the Endocrine Society for selecting me for this award! Looking forward to connecting with fellow recipients this year in Chicago. #ENDO2026

[Endocrine Society @TheEndoSociety]

Congratulations to our Early Career Forum program winners. Our awardees will attend ENDO 2026 and participate in a unique workshop to connect them with experts in the field. View our awardees: https://t.co/BHcQqeAjAG #ENDO2026 #endocrinology

[Euro J Endocrinology @EJEndo]

IGF-I and symptoms of acromegaly according to time since somatostatin receptor ligand injection by Ilan Remba-Shapiro et al

EJE Volume 193, Issue 4, October 2025
👉 https://t.co/Wa55qsorj5
ESE members free via 👉 https://t.co/AxTMoXOoqV

#endocrinology

[Alberto Moscona-Nissan @Alberto_Moscona]

@armz_md @BIDMChealth @harvardmed Mucho éxito!!!

[Alberto Moscona-Nissan @Alberto_Moscona]

@alberto_guijosa @UPMexico @DanaFarber @harvardmed Any program will be very lucky to have you!!

[Niki Karavitaki @Karavitaki_Niki]

Just out - great collaborative work! Full-text access https://t.co/GpzbyKCfZ1 in Nature Reviews Endocrinology @PituitarySoc @TheEndoSociety @ESEndocrinology @UoB_MSS @unibirm_CMH @BHPComms

[Alberto Moscona-Nissan @Alberto_Moscona]

Had a great time at #ENDO2025 @TheEndoSociety and at the 19th International Pituitary Congress by the @PituitarySoc.

Honored to have presented our work from @MassGenBrigham, receiving a poster award! Very proud as well to share two posters from my former lab in Mexico City.

[Aldo Ferreira Hermosillo @aldo_ferreira83]

What is the impact on metabolism and fertility of the medical treatments for obesity and bariatric surgery? We have reviewed this topic in our manuscript at @MetabolitesMDPI journal #obesity #weightloss #endocrinology
https://t.co/MDzrmaguHH

[Alberto Moscona-Nissan @Alberto_Moscona]

Excited to share our new publication from my previous lab, where we evaluated treatment-resistant lactotroph pituitary neuroendocrine tumors using spatial transcriptomics. https://t.co/S08FIC2BMC

[Alberto Moscona-Nissan @Alberto_Moscona]

@alfonso_rdz_96 @MariaMouraoMD @NESS_News Muchas felicidades !!

[Alberto Moscona-Nissan @Alberto_Moscona]

@UPMexico @MassGenBrigham @harvardmed Muchas gracias!! 🫶🏻

[Alberto Moscona-Nissan @Alberto_Moscona]

Very excited to share that I will be joining @MassGenBrigham at @harvardmed as a Postdoctoral Research Fellow after passing Step 1 and graduating from Med School at @UPMexico. Incredibly grateful to my mentors, family, and friends for their constant support.

[Alberto Moscona-Nissan @Alberto_Moscona]

@Gon_Hagerman17 @MassGenBrigham @harvardmed @UPMexico Muchas gracias Gon!!

[Alberto Moscona-Nissan @Alberto_Moscona]

@Alecman98 Congratulations!!!

[Alberto Moscona-Nissan @Alberto_Moscona]

@CojucG Congratulations !!!

[AJKD @AJKDonline]

In recognition of #WorldKidneyDay on March 13, the editors present a collection of AJKD articles that highlight kidney disease research across the world:

https://t.co/lsv13uxsUY (FREE)

@WorldKidneyDay

[Alberto Moscona-Nissan @Alberto_Moscona]

@Alecman98 @ECFMG_IMG Congratulations!!

[Alberto Moscona-Nissan @Alberto_Moscona]

@alberto_guijosa @DanaFarber @harvardmed Muchas Felicidades!!!

[Alberto Guijosa, MD @alberto_guijosa]

Excited to share our study @AJKDonline, revealing the underrepresentation of LMICs in 20 years of CKD drug RCTs (1,366 trials, 301,158 participants). We found a strong positive correlation between RCT participation and the Human Development Index, health expenditure, and R&D expenditure. As a Mexican medical graduate, I’m hopeful this work draws attention to the need for more inclusive global research. https://t.co/oE2QAEtC03